80 results
8-K
EX-99.1
MCRB
Seres Therapeutics Inc
5 Mar 24
Seres Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
7:05am
enrollment forms as well as progress on the reimbursement front. In close collaboration with our colleagues at Nestlé Health Science, we will continue
8-K
EX-3.1
l3xywtbyvflrdn
2 Jan 24
Amendments to Articles of Incorporation or Bylaws
4:05pm
8-K
EX-99.2
2avgb
9 May 23
Seres Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Updates
8:16am
8-K
EX-10.1
jxuol
27 Apr 23
Entry into a Material Definitive Agreement
7:26am
PRE 14A
91n1f9
14 Apr 23
Preliminary proxy
4:30pm
8-K
EX-10.1
39eduv 74aqf5
14 Dec 22
Entry into a Material Definitive Agreement
4:10pm
8-K
EX-10.2
990r4 bm62
30 Jun 22
Entry into a Material Definitive Agreement
8:02am
8-K
EX-10.1
f3sgkcdeoihqvj
30 Jun 22
Entry into a Material Definitive Agreement
8:02am